kr198.80
2.53% day before yesterday
Stockholm, Nov 07, 05:30 pm CET
ISIN
SE0009858152
Symbol
BONEX

Bonesupport Holding AB Stock price

kr198.80
-76.20 27.71% 1M
-99.80 33.42% 6M
-188.00 48.60% YTD
-149.40 42.91% 1Y
+110.75 125.78% 3Y
+134.40 208.70% 5Y
+166.80 521.25% 10Y
+166.80 521.25% 20Y
Stockholm, Closing price Fri, Nov 07 2025
+4.90 2.53%
ISIN
SE0009858152
Symbol
BONEX
Industry

New AI Insights on Bonesupport Holding AB Insights AI Insights on Bonesupport Holding AB

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
kr12.8b
Enterprise Value
kr12.4b
Net debt
positive
Cash
kr379.0m
Shares outstanding
66.8m
Valuation (TTM | estimate)
P/E
86.8 | 73.1
P/S
11.4 | 10.4
EV/Sales
11.1 | 10.1
EV/FCF
52.7
P/B
15.3
Financial Health
Equity Ratio
82.7%
Return on Equity
18.4%
ROCE
25.5%
ROIC
34.2%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
kr1.1b | kr1.2b
EBITDA
kr220.9m | kr253.9m
EBIT
kr214.1m | kr250.8m
Net Income
kr151.9m | kr181.5m
Free Cash Flow
kr235.3m
Growth (TTM | estimate)
Revenue
37.4% | 37.2%
EBITDA
110.8% | 216.9%
EBIT
127.1% | 244.1%
Net Income
67.7% | 35.7%
Free Cash Flow
7,969.6%
Margin (TTM | estimate)
Gross
92.6%
EBITDA
19.7% | 20.6%
EBIT
19.1%
Net
13.6% | 14.7%
Free Cash Flow
21.0%
More
EPS
kr2.3
FCF per Share
kr3.5
Short interest
-
Employees
140
Rev per Employee
kr6.4m
Show more

Is Bonesupport Holding AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Bonesupport Holding AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Bonesupport Holding AB forecast:

11x Buy
92%
1x Hold
8%

Analyst Opinions

12 Analysts have issued a Bonesupport Holding AB forecast:

Buy
92%
Hold
8%

Financial data from Bonesupport Holding AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,119 1,119
37% 37%
100%
- Direct Costs 83 83
34% 34%
7%
1,036 1,036
38% 38%
93%
- Selling and Administrative Expenses 705 705
23% 23%
63%
- Research and Development Expense 90 90
25% 25%
8%
221 221
111% 111%
20%
- Depreciation and Amortization 6.80 6.80
35% 35%
1%
EBIT (Operating Income) EBIT 214 214
127% 127%
19%
Net Profit 152 152
68% 68%
14%

In millions SEK.

Don't miss a Thing! We will send you all news about Bonesupport Holding AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.

Head office Sweden
CEO Mr. Billback
Employees 140
Founded 2010
Website www.bonesupport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today